126 related articles for article (PubMed ID: 38462165)
1. YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation.
Zhao X; Lv S; Li N; Zou Q; Sun L; Song T
J Biol Chem; 2024 Apr; 300(4):107152. PubMed ID: 38462165
[TBL] [Abstract][Full Text] [Related]
2. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
3. Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.
Du C; Lv C; Feng Y; Yu S
J Exp Clin Cancer Res; 2020 Oct; 39(1):223. PubMed ID: 33087165
[TBL] [Abstract][Full Text] [Related]
4. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
[TBL] [Abstract][Full Text] [Related]
5. SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.
Hou G; Zhao X; Li L; Yang Q; Liu X; Huang C; Lu R; Chen R; Wang Y; Jiang B; Yu J
Nucleic Acids Res; 2021 Mar; 49(5):2859-2877. PubMed ID: 33577677
[TBL] [Abstract][Full Text] [Related]
6. SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication.
Sugiokto FG; Saiada F; Zhang K; Li R
mBio; 2024 Feb; 15(2):e0316823. PubMed ID: 38236021
[TBL] [Abstract][Full Text] [Related]
7. YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation.
Bai X; Chen J; Zhang W; Zhou S; Dong L; Huang J; He X
Cancer Sci; 2023 Nov; 114(11):4299-4313. PubMed ID: 37700438
[TBL] [Abstract][Full Text] [Related]
8. Understanding YTHDF2-mediated mRNA degradation by m6A-BERT-Deg.
Zhang TH; Jo S; Zhang M; Wang K; Gao SJ; Huang Y
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38622358
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of OTU domain-containing ubiquitin aldehyde-binding protein 1 exacerbates colorectal cancer malignancy by inhibiting protein degradation of β-Catenin via Ubiquitin-proteasome pathway.
Ye D; Wang S; Wang X; Lin Y; Huang Y; Chi P
Bioengineered; 2022 Apr; 13(4):9106-9116. PubMed ID: 35354355
[TBL] [Abstract][Full Text] [Related]
10. OTUB1 de-ubiquitinating enzyme promotes prostate cancer cell invasion in vitro and tumorigenesis in vivo.
Iglesias-Gato D; Chuan YC; Jiang N; Svensson C; Bao J; Paul I; Egevad L; Kessler BM; Wikström P; Niu Y; Flores-Morales A
Mol Cancer; 2015 Jan; 14(1):8. PubMed ID: 25623341
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
[TBL] [Abstract][Full Text] [Related]
12. YTHDF1 promotes gallbladder cancer progression via post-transcriptional regulation of the m6A/UHRF1 axis.
Chen J; Bai X; Zhang W; Yan Z; Liu Y; Zhou S; Wu X; He X; Yang A
J Cell Mol Med; 2024 May; 28(9):e18328. PubMed ID: 38683130
[TBL] [Abstract][Full Text] [Related]
13. The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells.
Dixit D; Prager BC; Gimple RC; Poh HX; Wang Y; Wu Q; Qiu Z; Kidwell RL; Kim LJY; Xie Q; Vitting-Seerup K; Bhargava S; Dong Z; Jiang L; Zhu Z; Hamerlik P; Jaffrey SR; Zhao JC; Wang X; Rich JN
Cancer Discov; 2021 Feb; 11(2):480-499. PubMed ID: 33023892
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1.
Zhu D; Xu R; Huang X; Tang Z; Tian Y; Zhang J; Zheng X
Cell Death Differ; 2021 Jun; 28(6):1773-1789. PubMed ID: 33328570
[TBL] [Abstract][Full Text] [Related]
15. YTHDF2 promotes multiple myeloma cell proliferation via STAT5A/MAP2K2/p-ERK axis.
Hua Z; Wei R; Guo M; Lin Z; Yu X; Li X; Gu C; Yang Y
Oncogene; 2022 Mar; 41(10):1482-1491. PubMed ID: 35075244
[TBL] [Abstract][Full Text] [Related]
16. OTUB1 stabilizes mismatch repair protein MSH2 by blocking ubiquitination.
Wu Q; Huang Y; Gu L; Chang Z; Li GM
J Biol Chem; 2021; 296():100466. PubMed ID: 33640455
[TBL] [Abstract][Full Text] [Related]
17. YTH domain family 2 promotes lung cancer cell growth by facilitating 6-phosphogluconate dehydrogenase mRNA translation.
Sheng H; Li Z; Su S; Sun W; Zhang X; Li L; Li J; Liu S; Lu B; Zhang S; Shan C
Carcinogenesis; 2020 Jul; 41(5):541-550. PubMed ID: 31504235
[TBL] [Abstract][Full Text] [Related]
18. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
Yang Z; Cai Z; Yang C; Luo Z; Bao X
EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
[TBL] [Abstract][Full Text] [Related]
19. Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein.
Li Y; Sun XX; Elferich J; Shinde U; David LL; Dai MS
J Biol Chem; 2014 Feb; 289(8):5097-108. PubMed ID: 24403071
[TBL] [Abstract][Full Text] [Related]
20. Ythdf2-mediated m
Li M; Zhao X; Wang W; Shi H; Pan Q; Lu Z; Perez SP; Suganthan R; He C; Bjørås M; Klungland A
Genome Biol; 2018 May; 19(1):69. PubMed ID: 29855337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
